Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-03-16 Purchase |
2021-03-18 4:43 pm |
Prometheus Biosciences Inc. | RXDX | Cormorant Asset Management LP Chen Bihua Cormorant Global Healthcare Master Fund LP Cormorant Private Healthcare Fund III LP Former 10% Owner |
375,000 | $19 | $7,125,000 | 2,223,022 (Indirect) |
View |
| 2021-03-16 Purchase |
2021-03-17 7:47 pm |
Prometheus Biosciences Inc. | RXDX | Point72 Biotech Private Investments LLC Differentiated Ventures Investments LLC 72 Investment Holdings LLC COHEN STEVEN A/SAC CAPITAL MGMT LP Former 10% Owner |
800,000 | $19 | $15,200,000 | 2,648,024 (Indirect) |
View |
| 2021-03-16 Purchase |
2021-03-16 9:49 pm |
Prometheus Biosciences Inc. | RXDX | Stenhouse Mark Chief Operating Officer |
14,000 | $19 | $266,000 | 14,000 (Direct) |
View |
| 2021-03-16 Purchase |
2021-03-16 9:48 pm |
Prometheus Biosciences Inc. | RXDX | PAPA JOSEPH C Director |
15,000 | $19 | $285,000 | 15,000 (Direct) |
View |
| 2021-03-16 Purchase |
2021-03-16 9:47 pm |
Prometheus Biosciences Inc. | RXDX | Adams Helen C. Director |
500 | $19 | $9,500 | 500 (Direct) |
View |
| 2021-03-16 Purchase |
2021-03-16 8:30 pm |
Prometheus Biosciences Inc. | RXDX | PERCEPTIVE ADVISORS LLC PERCEPTIVE LIFE SCIENCES MASTER FUND LTD EDELMAN JOSEPH 10% Owner |
850,000 | $19 | $16,150,000 | 3,314,032 (Indirect) |
View |
| 2021-03-16 Purchase |
2021-03-16 7:57 pm |
Prometheus Biosciences Inc. | RXDX | RTW INVESTMENTS LP WONG RODERICK 10% Owner |
800,000 | $19 | $15,200,000 | 3,264,031 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-05-19 Option Award |
2022-05-20 7:18 pm |
N/A 2032-05-18 |
Prometheus Biosciences Inc. | RXDX | Adams Helen C. Director |
21,526 | $0 | 21,526 (Direct) |
View |
| 2022-05-20 Option Award |
2022-05-20 7:15 pm |
2025-05-20 2032-05-19 |
Prometheus Biosciences Inc. | RXDX | Stenhouse Mark Chief Operating Officer |
86,582 | $0 | 86,582 (Direct) |
View |
| 2022-05-20 Option Award |
2022-05-20 7:13 pm |
2025-05-20 2032-05-19 |
Prometheus Biosciences Inc. | RXDX | Marshall Keith W Chief Financial Officer |
86,582 | $0 | 86,582 (Direct) |
View |
| 2022-05-20 Option Award |
2022-05-20 7:11 pm |
2025-05-20 2032-05-19 |
Prometheus Biosciences Inc. | RXDX | McKenna Mark C. Chairman, President & CEO |
246,639 | $0 | 246,639 (Direct) |
View |
| 2022-04-05 Other |
2022-04-05 5:49 pm |
N/A N/A |
Prometheus Biosciences Inc. | RXDX | Cedars Sinai Intellectual Property Co 10% Owner |
142,376 | $0 | 5,008,508 (Indirect) |
View |
| 2021-12-01 Exercise |
2021-12-03 7:02 pm |
N/A 2029-11-06 |
Prometheus Biosciences Inc. | RXDX | McKenna Mark C. Chairman, President & CEO |
15,400 | $0 | 137,931 (Direct) |
View |
| 2021-12-01 Exercise |
2021-12-03 7:02 pm |
N/A N/A |
Prometheus Biosciences Inc. | RXDX | McKenna Mark C. Chairman, President & CEO |
15,400 | $2.9 | 137,931 (Direct) |
View |
| 2021-11-14 Option Award |
2021-11-16 9:19 pm |
N/A 2031-11-13 |
Prometheus Biosciences Inc. | RXDX | Hassan Fred Director |
541 | $0 | 541 (Direct) |
View |
| 2021-11-14 Option Award |
2021-11-16 9:17 pm |
N/A 2031-11-13 |
Prometheus Biosciences Inc. | RXDX | Adams Helen C. Director |
1,083 | $0 | 1,083 (Direct) |
View |
| 2021-11-14 Option Award |
2021-11-16 9:15 pm |
N/A 2031-11-13 |
Prometheus Biosciences Inc. | RXDX | PAPA JOSEPH C Director |
2,165 | $0 | 2,165 (Direct) |
View |
| 2021-11-14 Option Award |
2021-11-16 9:12 pm |
N/A 2031-11-13 |
Prometheus Biosciences Inc. | RXDX | Andrews Timothy K. General Counsel |
54,132 | $0 | 54,132 (Direct) |
View |
| 2021-11-14 Option Award |
2021-11-16 9:10 pm |
N/A 2031-11-13 |
Prometheus Biosciences Inc. | RXDX | Stenhouse Mark Chief Operating Officer |
70,371 | $0 | 70,371 (Direct) |
View |
| 2021-11-14 Option Award |
2021-11-16 9:08 pm |
N/A 2031-11-13 |
Prometheus Biosciences Inc. | RXDX | Marshall Keith W Chief Financial Officer |
102,155 | $0 | 102,155 (Direct) |
View |
| 2021-11-14 Option Award |
2021-11-16 9:06 pm |
N/A 2031-11-13 |
Prometheus Biosciences Inc. | RXDX | Luo Allison Chief Medical Officer |
113,677 | $0 | 113,677 (Direct) |
View |
| 2021-11-14 Option Award |
2021-11-16 9:03 pm |
N/A 2031-11-13 |
Prometheus Biosciences Inc. | RXDX | McKenna Mark C. Chairman, President & CEO |
290,000 | $0 | 290,000 (Direct) |
View |
| 2021-09-08 Option Award |
2021-09-15 8:09 pm |
N/A 2031-09-07 |
Prometheus Biosciences Inc. | RXDX | Luo Allison Chief Medical Officer |
4,500 | $0 | 4,500 (Indirect) |
View |
Ownership |
2021-06-25 6:03 pm |
N/A N/A |
Prometheus Biosciences Inc. | RXDX | Cedars Sinai Intellectual Property Co 10% Owner |
0 | $0 | 5,008,508 (Indirect) |
View |
| 2021-05-14 Option Award |
2021-05-17 7:24 pm |
N/A 2031-05-13 |
Prometheus Biosciences Inc. | RXDX | Hassan Fred Director |
40,000 | $0 | 40,000 (Direct) |
View |
| 2021-04-14 Option Award |
2021-04-16 6:46 pm |
N/A 2031-04-13 |
Prometheus Biosciences Inc. | RXDX | Laur James Director |
40,000 | $0 | 40,000 (Direct) |
View |
| 2021-04-14 Option Award |
2021-04-16 6:40 pm |
N/A 2031-04-13 |
Prometheus Biosciences Inc. | RXDX | Hendrix Martin Director |
40,000 | $0 | 40,000 (Direct) |
View |
| 2021-03-16 Conversion |
2021-03-18 4:43 pm |
N/A N/A |
Prometheus Biosciences Inc. | RXDX | Cormorant Asset Management LP Chen Bihua Cormorant Global Healthcare Master Fund LP Cormorant Private Healthcare Fund III LP Former 10% Owner |
3,696,045 | $0 | 2,223,022 (Indirect) |
View |
Ownership(A) |
2021-03-18 4:41 pm |
N/A N/A |
Prometheus Biosciences Inc. | RXDX | Cormorant Asset Management LP Chen Bihua Cormorant Global Healthcare Master Fund LP Cormorant Private Healthcare Fund III LP 10% Owner |
0 | $0 | 1,848,022 (Indirect) |
View |
| 2021-03-16 Conversion |
2021-03-17 7:47 pm |
N/A N/A |
Prometheus Biosciences Inc. | RXDX | Point72 Biotech Private Investments LLC Differentiated Ventures Investments LLC 72 Investment Holdings LLC COHEN STEVEN A/SAC CAPITAL MGMT LP Former 10% Owner |
20,328,269 | $0 | 2,648,024 (Indirect) |
View |
| 2021-03-16 Conversion |
2021-03-16 9:53 pm |
N/A N/A |
Prometheus Biosciences Inc. | RXDX | CEDARS SINAI MEDICAL CENTER 10% Owner |
48,576,089 | $0 | 5,008,508 (Direct) |
View |
| 2021-03-16 Conversion |
2021-03-16 9:51 pm |
N/A N/A |
Prometheus Biosciences Inc. | RXDX | Yamada Tadataka and Chairman of the Board |
146,667 | $0 | 13,333 (Direct) |
View |
| 2021-03-16 Conversion |
2021-03-16 8:30 pm |
N/A N/A |
Prometheus Biosciences Inc. | RXDX | PERCEPTIVE ADVISORS LLC PERCEPTIVE LIFE SCIENCES MASTER FUND LTD EDELMAN JOSEPH 10% Owner |
27,104,358 | $0 | 3,314,032 (Indirect) |
View |
| 2021-03-16 Conversion |
2021-03-16 7:57 pm |
N/A N/A |
Prometheus Biosciences Inc. | RXDX | RTW INVESTMENTS LP WONG RODERICK 10% Owner |
27,104,357 | $0 | 3,264,031 (Indirect) |
View |
Ownership |
2021-03-12 07:20 am |
N/A N/A |
Prometheus Biosciences Inc. | RXDX | NESTLE SA Societe des Produits Nestle S.A. 10% Owner |
0 | $0 | 3,730,841 (Indirect) |
View |
| 2021-03-11 Option Award |
2021-03-11 9:47 pm |
N/A 2031-03-10 |
Prometheus Biosciences Inc. | RXDX | Szela Mary T Director |
40,000 | $0 | 40,000 (Direct) |
View |
Ownership |
2021-03-11 9:41 pm |
N/A N/A |
Prometheus Biosciences Inc. | RXDX | Point72 Biotech Private Investments LLC Differentiated Ventures Investments LLC 72 Investment Holdings LLC COHEN STEVEN A/SAC CAPITAL MGMT LP 10% Owner |
0 | $0 | 1,848,023 (Indirect) |
View |
Ownership |
2021-03-11 9:39 pm |
N/A N/A |
Prometheus Biosciences Inc. | RXDX | CEDARS SINAI MEDICAL CENTER 10% Owner |
0 | $0 | 5,008,507 (Direct) |
View |
Ownership |
2021-03-11 9:38 pm |
N/A 2030-12-17 |
Prometheus Biosciences Inc. | RXDX | Andrews Timothy K. General Counsel |
0 | $0 | 153,495 (Direct) |
View |
Ownership |
2021-03-11 9:34 pm |
N/A N/A |
Prometheus Biosciences Inc. | RXDX | Yamada Tadataka and Chairman of the Board |
0 | $0 | 403,286 (Direct) |
View |
Ownership |
2021-03-11 9:31 pm |
N/A 2031-02-04 |
Prometheus Biosciences Inc. | RXDX | Swain Judith L Director |
0 | $0 | 30,000 (Direct) |
View |
Ownership |
2021-03-11 9:29 pm |
2021-02-04 2028-05-22 |
Prometheus Biosciences Inc. | RXDX | Stenhouse Mark Chief Operating Officer |
0 | $0 | 280,000 (Direct) |
View |
Ownership |
2021-03-11 9:27 pm |
N/A 2030-08-24 |
Prometheus Biosciences Inc. | RXDX | PAPA JOSEPH C Director |
0 | $0 | 64,992 (Direct) |
View |